RECRUITINGINTERVENTIONAL

Comparison of the Efficacy of One Level and Tow Level of Bilateral Thoracic Erector Spinae Plane Block Combined With General Anesthesia in Laparoscopic Bariatric Surgery for Obese Patients: Randomized Controlled Trial

Comparison of the Efficacy of One Level and Two Level of Bilateral Thoracic Erector Spinae Plane Block Combined With General Anesthesia in Laparoscopic Bariatric Surgery for Obese Patients: Randomized Controlled Trial.

About This Trial

comparison of the feasibility and efficacy of the one-level and two-level thoracic ESP block and their effect on intraoperative and postoperative analgesia in bariatric surgeries.

Who May Be Eligible (Plain English)

Who May Qualify: - • Patient age ranges 18 to 60 years old - Obese patients ; Body mass index(BMI) ≥ 35 - 50 kg/m2 - American Society of Anesthesiologists (ASA) physical status classes II to III - Patients scheduled for laparoscopic bariatric surgery i.e. sleeve gastrectomy and/or Roux-en-Y gastric bypass (RYGB) surgeries Who Should NOT Join This Trial: - • Refusal of regional block - Patients with neurological, psychological disorders or those lacking cooperation - Patients scheduled for concomitant laparoscopic cholecystectomy or paraumbilical hernia repair or those with history of previous bariatric surgery or obstructive sleep apnea - Patients with anatomic abnormalities at site of injection, skin lesions or wounds at site of proposed needle insertion. - Patients with bleeding disorders defined as (INR \>1.4) and/ or (platelet count \<100,000/µL) - Patients with hepatic disease e.g. liver cell failure or hepatic malignancy or hepatic enlargement. - Patients who are allergic to amide local anesthetics. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * • Patient age ranges 18 to 60 years old * Obese patients ; Body mass index(BMI) ≥ 35 - 50 kg/m2 * American Society of Anesthesiologists (ASA) physical status classes II to III * Patients scheduled for laparoscopic bariatric surgery i.e. sleeve gastrectomy and/or Roux-en-Y gastric bypass (RYGB) surgeries Exclusion Criteria: * • Refusal of regional block * Patients with neurological, psychological disorders or those lacking cooperation * Patients scheduled for concomitant laparoscopic cholecystectomy or paraumbilical hernia repair or those with history of previous bariatric surgery or obstructive sleep apnea * Patients with anatomic abnormalities at site of injection, skin lesions or wounds at site of proposed needle insertion. * Patients with bleeding disorders defined as (INR \>1.4) and/ or (platelet count \<100,000/µL) * Patients with hepatic disease e.g. liver cell failure or hepatic malignancy or hepatic enlargement. * Patients who are allergic to amide local anesthetics.

Treatments Being Tested

PROCEDURE

bilateral thoracic erector spinae plane block combined with general anesthesia in laparoscopic bariatric surgery in obese patients

using the in-plane approach, in caudal -to- cephalad direction, through the interfascial plane between the Erector Spinae and the underlying transverse process under strict aseptic precautions until the tip is deep to erector spinae muscle. the block will be performed bilaterally by injecting 60 mL of 0.25% bupivacaine (15 mL into each of four site) into the fascial plane between the deep surface of the Erector Spinae muscle and the bilateral transverse processes of the thoracic vertebrae 5 and 10 (at the most lateral part of the transverse process)

Locations (1)

Cairo University

Cairo, Egypt